Two biotechs staking claim in fight against Ebola

Stocks of two of the biotech companies involved in the battle against Ebola are outpacing their peers, climbing by double digits on prospects they may have a leg up on the competition.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.